Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol

NCT07166783 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Health Subjects

Interventions

DRUG: Tolvaptan

Sponsor

Otsuka Beijing Research Institute